Page last updated: 2024-08-22

nitroxoline and nitrofurantoin

nitroxoline has been researched along with nitrofurantoin in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L	1
Chapman, E; Chitre, S; Hoang, QQ; Howe, C; Johnson, SM; Park, Y; Ray, AM; Sivinski, J; Stevens, M; Washburn, A	1
Soloveĭ, BV; Soloveĭ, TP	1
Huttner, A; Koch, BCP; Mouton, JW; Muller, AE; Wijma, RA	1

Reviews

1 review(s) available for nitroxoline and nitrofurantoin

Article	Year
Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Anti-Bacterial Agents; Crystallization; Germany; Humans; Nitrofurantoin; Nitroquinolines; Urinary Tract Infections	2018

Trials

1 trial(s) available for nitroxoline and nitrofurantoin

Article	Year
[Intensive combined therapy of patients with urogenital tuberculosis]. Problemy tuberkuleza, 1995, Issue:1 Topics: Adult; Anti-Infective Agents, Urinary; Antitubercular Agents; Candicidin; Drug Therapy, Combination; Humans; Middle Aged; Nitrofurantoin; Nitroquinolines; Treatment Outcome; Tuberculosis, Urogenital	1995

Other Studies

2 other study(ies) available for nitroxoline and nitrofurantoin

Article	Year
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching. Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21 Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity	2013
Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugs. Bioorganic & medicinal chemistry, 2020, 11-15, Volume: 28, Issue:22 Topics: Anti-Bacterial Agents; Chaperonin 60; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Nitrofurans; Prodrugs; Structure-Activity Relationship	2020

Article

Year

Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.

Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21

Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity

2013

Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugs.

Bioorganic & medicinal chemistry, 2020, 11-15, Volume: 28, Issue:22

Topics: Anti-Bacterial Agents; Chaperonin 60; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Nitrofurans; Prodrugs; Structure-Activity Relationship

2020